دورية أكاديمية

Sensitization to isobornyl acrylate in a tertiary Belgian hospital.

التفاصيل البيبلوغرافية
العنوان: Sensitization to isobornyl acrylate in a tertiary Belgian hospital.
المؤلفون: Herman, Anne, Baeck, Marie
المساهمون: UCL - (SLuc) Service de dermatologie, UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie, UCL - (SLuc) Centre de l'allergie
المصدر: Contact dermatitis, Vol. 85, no. 1, p. 105-106 (2021)
بيانات النشر: Wiley
سنة النشر: 2021
المجموعة: DIAL@UCL (Université catholique de Louvain)
مصطلحات موضوعية: Acrylates, Allergens, Belgium, Camphanes, Dermatitis, Allergic Contact, Occupational, Female, Humans, Male, Medical Staff, Hospital, Patch Tests, allergic contact dermatitis, glucose sensor, insulin pump, isobornyl acrylate, medical device, sensitization
الوصف: Allergic contact dermatitis (ACD) to isobornyl acrylate (IBOA) hasbeen largely reported. Consequently, it was recognized as the“Con-tact Allergen of the Year 2020â€by the American Contact DermatitisSociety. The prevalence of IBOA sensitization is estimated to be 0.7%to 3.8% in patients with adverse skin reactions to medical devices(MDs) used in diabetes.1,2However, to our knowledge, the prevalenceof sensitization to IBOA in the general patch-tested population hasnot yet been established. [.]
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 0105-1873
1600-0536
العلاقة: boreal:260955; http://hdl.handle.net/2078.1/260955Test; info:pmid/33527358; urn:ISSN:0105-1873; urn:EISSN:1600-0536
DOI: 10.1111/cod.13797
الإتاحة: https://doi.org/10.1111/cod.13797Test
http://hdl.handle.net/2078.1/260955Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.46FC2AE6
قاعدة البيانات: BASE
الوصف
تدمد:01051873
16000536
DOI:10.1111/cod.13797